LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Construction & Landscaping Businesses for Sale
Automotive Businesses for Sale
Furniture & Home Decor Businesses for Sale
Farms & Vineyards for Sale
Smoke & Vape Shops for Sale
Bars, Pubs & Nightclubs for Sale
Liquor Store Businesses for Sale
Cleaning & Janitorial Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Grocery Stores & Delis for Sale
Healthcare & Medical Franchise Opportunities
Gift & Flower Shop Franchise Opportunities
Bars & Pubs Franchises for Sale
Construction & Landscaping Franchise Opportunities
Laundromat & Dry Cleaning Franchise Opportunities
Smoke & Vape Shop Franchises for Sale
Warehouse & Storage Franchise for Sale
Consultancy & Training Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Environmental Franchise Opportunities
Land & Developments for Sale
Commercial Spaces for Sale or Lease
Medical Buildings for Sale or Lease
Plazas for Sale
Miscellaneous Properties for Sale or Lease
Industrial Units for Sale or Rent
Apartment Buildings for Sale
Places of Worship for Sale
Houses & Condos for Sale or Lease
Office Spaces for Sale or Rent
An email will be sent to registered email address.
Please select if you are: